BE881752A - NOVEL HYDROXYLATED PYRIMIDINE DERIVATIVES, THEIR PREPARATION AND THEIR THERAPEUTIC USE - Google Patents

NOVEL HYDROXYLATED PYRIMIDINE DERIVATIVES, THEIR PREPARATION AND THEIR THERAPEUTIC USE

Info

Publication number
BE881752A
BE881752A BE0/199421A BE199421A BE881752A BE 881752 A BE881752 A BE 881752A BE 0/199421 A BE0/199421 A BE 0/199421A BE 199421 A BE199421 A BE 199421A BE 881752 A BE881752 A BE 881752A
Authority
BE
Belgium
Prior art keywords
preparation
therapeutic use
pyrimidine derivatives
novel hydroxylated
hydroxylated
Prior art date
Application number
BE0/199421A
Other languages
French (fr)
Inventor
A Esanu
Original Assignee
Soc D Etudes Prod Chimique
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=26270867&utm_source=***_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=BE881752(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Soc D Etudes Prod Chimique filed Critical Soc D Etudes Prod Chimique
Publication of BE881752A publication Critical patent/BE881752A/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D239/00Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/46Two or more oxygen, sulphur or nitrogen atoms
    • C07D239/47One nitrogen atom and one oxygen or sulfur atom, e.g. cytosine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D239/00Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/46Two or more oxygen, sulphur or nitrogen atoms
    • C07D239/52Two oxygen atoms
    • C07D239/54Two oxygen atoms as doubly bound oxygen atoms or as unsubstituted hydroxy radicals
    • C07D239/545Two oxygen atoms as doubly bound oxygen atoms or as unsubstituted hydroxy radicals with other hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
BE0/199421A 1979-03-10 1980-02-15 NOVEL HYDROXYLATED PYRIMIDINE DERIVATIVES, THEIR PREPARATION AND THEIR THERAPEUTIC USE BE881752A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB7908494 1979-03-10
GB7914987 1979-04-30

Publications (1)

Publication Number Publication Date
BE881752A true BE881752A (en) 1980-05-30

Family

ID=26270867

Family Applications (1)

Application Number Title Priority Date Filing Date
BE0/199421A BE881752A (en) 1979-03-10 1980-02-15 NOVEL HYDROXYLATED PYRIMIDINE DERIVATIVES, THEIR PREPARATION AND THEIR THERAPEUTIC USE

Country Status (24)

Country Link
JP (1) JPS55122768A (en)
AR (1) AR222691A1 (en)
AU (1) AU533547B2 (en)
BE (1) BE881752A (en)
CA (1) CA1132561A (en)
CH (1) CH644368A5 (en)
DE (3) DE3009071C2 (en)
EG (1) EG14282A (en)
FI (1) FI66357C (en)
FR (2) FR2451370A1 (en)
GB (1) GB2045756B (en)
HK (1) HK55383A (en)
IE (1) IE49547B1 (en)
IN (1) IN153791B (en)
LU (1) LU82185A1 (en)
MX (1) MX6218E (en)
MY (1) MY8400200A (en)
NL (1) NL184833C (en)
NO (1) NO154054C (en)
NZ (1) NZ192927A (en)
OA (1) OA06484A (en)
PT (1) PT70882A (en)
SE (1) SE435180B (en)
SG (1) SG22683G (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5348957A (en) * 1991-09-09 1994-09-20 Warner-Lambert Company 5-hydroxy-2-pyrimidinylmethylene derivatives useful as antiinflammatory agents

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BE894517A (en) * 1981-10-16 1983-01-17 Sod Conseils Rech Applic NEW ISOPROPYLAMINO PYRIMIDINE DERIVATIVE, ITS PREPARATION AND THERAPEUTIC COMPOSITION BASED ON ITS COMPOUNDS
US4673677A (en) * 1983-10-03 1987-06-16 Pfizer Inc. Method for treatment of gastrointestinal disorders
US4554276A (en) * 1983-10-03 1985-11-19 Pfizer Inc. 2-Amino-5-hydroxy-4-methylpyrimidine derivatives
US4711888A (en) 1985-07-24 1987-12-08 Pfizer Inc. Hydroxy and alkoxy pyrimidines
WO1989000423A1 (en) * 1987-07-09 1989-01-26 Pfizer Inc. 2-amino-5-hydroxy-4-pyrimidones
US4910204A (en) * 1988-06-28 1990-03-20 Pfizer Inc. 2-amino-5-hydroxy-4-pyrimidones
HU206337B (en) * 1988-12-29 1992-10-28 Mitsui Petrochemical Ind Process for producing pyrimidine derivatives and pharmaceutical compositions
US5264435A (en) * 1988-12-29 1993-11-23 Mitsui Petrochemical Industries, Ltd. Pyrimidines and their pharmaceutical acceptable salts, and their use as medicines
US4940712A (en) * 1989-05-26 1990-07-10 Pfizer Inc. Derivatives of hydroxyprimidines as leukotriene synthesis inhibitors
US5220025A (en) * 1992-02-24 1993-06-15 Warner-Lambert Company 2-substituted amino-4, 6-di-tertiary-butyl-5-hydroxy-1, 3-pyrimidines as antiinflammatory agents
US5196431A (en) * 1992-02-24 1993-03-23 Warner-Lambert Company 2-substituted amino-4, 6-di-tertiary-buthyl-5-hydroxy-1, 3-pyrimidines as antiinflammatory agents
US9133212B1 (en) * 2005-06-15 2015-09-15 Vanderbilt University Inhibitors of hemeprotein-catalyzed lipid peroxidation

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB741667A (en) * 1952-12-05 1955-12-07 Ici Ltd New pyrimidine derivatives
GB756189A (en) * 1954-02-01 1956-08-29 Ici Ltd New pyrimidine derivatives
ZA711152B (en) * 1970-03-02 1971-11-24 Ici Ltd Manufacture of pyrimidines
GB1525995A (en) * 1976-02-18 1978-09-27 Soc D Etudes Prod Chimique Aminopyrimidine salt

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5348957A (en) * 1991-09-09 1994-09-20 Warner-Lambert Company 5-hydroxy-2-pyrimidinylmethylene derivatives useful as antiinflammatory agents

Also Published As

Publication number Publication date
NL184833C (en) 1989-11-16
GB2045756A (en) 1980-11-05
LU82185A1 (en) 1980-06-06
SE435180B (en) 1984-09-10
IE800477L (en) 1980-09-10
AU5624880A (en) 1980-09-18
PT70882A (en) 1980-03-01
FI66357C (en) 1984-10-10
FR2451370A1 (en) 1980-10-10
JPS6126996B2 (en) 1986-06-23
NZ192927A (en) 1981-07-13
FI66357B (en) 1984-06-29
DE3016752C2 (en) 1987-06-25
GB2045756B (en) 1983-01-26
MX6218E (en) 1984-12-21
DE3050999A1 (en) 1985-08-14
JPS55122768A (en) 1980-09-20
DE3009071A1 (en) 1980-09-11
FR2451191B1 (en) 1983-04-29
HK55383A (en) 1983-11-25
MY8400200A (en) 1984-12-31
NO154054C (en) 1986-07-09
IN153791B (en) 1984-08-18
CA1132561A (en) 1982-09-28
AU533547B2 (en) 1983-12-01
AR222691A1 (en) 1981-06-15
NL184833B (en) 1989-06-16
DE3016752A1 (en) 1980-12-04
CH644368A5 (en) 1984-07-31
SG22683G (en) 1983-12-16
SE8001812L (en) 1980-09-11
NL8001289A (en) 1980-09-12
DE3009071C2 (en) 1985-11-14
NO154054B (en) 1986-04-01
NL184468B (en) 1989-03-01
FR2451370B1 (en) 1983-05-13
FR2451191A1 (en) 1980-10-10
IE49547B1 (en) 1985-10-30
EG14282A (en) 1983-09-30
NO800664L (en) 1980-09-11
DE3050999C2 (en) 1986-08-14
OA06484A (en) 1981-07-31
FI800566A (en) 1980-09-11

Similar Documents

Publication Publication Date Title
FR2487349B1 (en) HYDRONAPHTHALENE DERIVATIVES, THEIR PREPARATION AND THEIR THERAPEUTIC USE
LU80619A1 (en) PLEUROMUTILINE HETEROSIDIC DERIVATIVES AND THEIR THERAPEUTIC USE
FR2607507B1 (en) NOVEL A-D-OLIGONUCLEOTIDES DERIVATIVES, THEIR PREPARATION AND THEIR USE
BE873656A (en) NEW DERIVATIVES OF PYRIDINE, THEIR PREPARATION AND THEIR USE
BE870266A (en) ALPHA-HALOGENOMETHYL DERIVATIVES OF AMINES, THEIR PREPARATION AND USE
BE882601A (en) MERCAPTOACYLDIPEPTIDES, THEIR PREPARATION AND THEIR USE
BE881752A (en) NOVEL HYDROXYLATED PYRIMIDINE DERIVATIVES, THEIR PREPARATION AND THEIR THERAPEUTIC USE
FR2470134B1 (en) NOVEL ANTIBIOTICS, THEIR PREPARATION AND THEIR USE
BE873766A (en) 2-PYRROLIDONE DERIVATIVES AND THEIR PREPARATION
BE880220A (en) 1,2,4,5-TETRA-ALKYL-4-ARYLPIPERIDINES, THEIR THERAPEUTIC USE, THEIR PREPARATION AND THE SUITABLE INTERMEDIATES
BE882166A (en) 9-AMINOALKYLFLUORENES, THEIR PREPARATION AND THEIR THERAPEUTIC USE
BE865705A (en) NEW PROSTANE DERIVATIVES, THEIR PREPARATION PROCESS AND THEIR USE
BE888417A (en) NOVEL THEOPHYLLINYLMETHYLDIOXOLANE DERIVATIVES, PREPARATION METHODS THEREOF AND THERAPEUTIC APPLICATION THEREOF,
BE853949A (en) NEW DERIVATIVES OF INDAZOLYL- (4) -OXY-PROPANOL-AMINE, THEIR PREPARATION AND USE
FR2516509B1 (en) BENZYLIDENIC DERIVATIVES, THEIR PREPARATION AND THEIR THERAPEUTIC APPLICATION
BE869322A (en) ALPHA-HALOGENOMETHYL DERIVATIVES OF AMINOACIDS, THEIR PREPARATION AND THEIR USE
BE887430A (en) NEW INDANE DERIVATIVES, THEIR PREPARATION AND THEIR THERAPEUTIC APPLICATION
BE884990A (en) THIADIAZINE-AMINES, THEIR PREPARATION AND THEIR USE
BE882982A (en) NOVEL THIAZOLINO-AZETIDINONES DERIVATIVES AND THEIR PREPARATION
BE882167A (en) (1,1-BIPHENYL-2-YL) -PROPYL- AND BUTYLAMINES, THEIR PREPARATION AND THEIR THERAPEUTIC USE
BE876680A (en) ARYLALKYL- AND ARYLOXYALKYL- PHOSPHONATES, THEIR PREPARATION AND THERAPEUTIC USE
BE887471A (en) BENZYLIDENIC DERIVATIVES, THEIR PREPARATION AND THEIR USE
LU80161A1 (en) 2,1-BENZISOTHIAZOLES, THEIR PREPARATION AND THEIR THERAPEUTIC USE
BE891204A (en) NAPHTYRIDINE DERIVATIVES, THEIR PREPARATION AND THEIR THERAPEUTIC APPLICATION
BE886361A (en) BENZYLIDENIC DERIVATIVES, THEIR PREPARATION AND THEIR THERAPEUTIC APPLICATION

Legal Events

Date Code Title Description
RE Patent lapsed

Owner name: SOC. D ETUDES DE PRODUITS CHIMIQUES

Effective date: 19900228